With an IC50 value of 0.49 ± 0.1 μM, hispidulin was found to be a potent inhibitor of dipeptidyl peptidase-4 enzyme DPP-IV, as an effective therapeutic target for the management of diabetes mellitus. The gene discussed is DPP4; the disease is diabetes mellitus.